Prestige Biologics Co Ltd
KOSDAQ:334970
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Prestige Biologics Co Ltd
KOSDAQ:334970
|
KR |
|
S
|
Schneider Electric SE
F:SND
|
FR |
|
D
|
Disco Corp
F:D65
|
JP |
Intrinsic Value
The intrinsic value of Prestige Biologics Co Ltd (334970) under the Base Case is 10 834.7 KRW per share. Compared with the current market price of 1 260 KRW, the stock appears Undervalued by 88% .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Prestige Biologics Does
Prestige Biologics is a South Korean biopharmaceutical services company that helps drug makers develop and manufacture biologic medicines. Its work is centered on contract development and manufacturing, so it does not mainly sell its own branded drugs. Instead, it provides the technical know-how, facilities, and regulated production process needed to turn a biologic drug concept into something that can be made reliably for testing or commercial use.
- Headquarters
- Korea KR
- Employees
- 199
- IPO date
- Mar 11, 2021
Earnings Waterfall
Prestige Biologics Co Ltd
The intrinsic value for Prestige Biologics Co Ltd (334970) under the Base Case is 10 834.7 KRW.
Compared with the current market price of 1 260 KRW, the stock appears Undervalued by 88% .